www.bbc.co.uk
Once-yearly jab for HIV protection passes first trial hurdle - BBC News
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
#PrEP is an active hashtag on Bluesky. In the last 30 days, 50 people shared 106 posts with it — around 4 a day. Activity is down 10% versus the previous week, peaking on Jul 29 with 11 posts.
Tags most often used together with #PrEP.
www.bbc.co.uk
Once-yearly jab for HIV protection passes first trial hurdle - BBC News
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
www.pharmastar.it
Lenacapavir conferma nel lungo termine l'efficacia protettiva contro l'HIV della PrEP semestrale
I nuovi risultati degli studi di estensione open-label PURPOSE 1 e PURPOSE 2 confermano che la profilassi pre-esposizione (PrEP) con lenacapavir somministrato due volte l'anno mantiene un'elevatissima...
www.nejm.org
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons | NEJM
Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of HIV infection in cisgender women. The efficacy of lenacapavir for preexposure prophylaxis (PrEP) in cisgende...
www.attitude.co.uk
Terrence Higgins Trust CEO: 'Why 2026 must be the year we unlock PrEP through community pharmacies' (EXCLUSIVE)
"We have the tools, the evidence and the opportunity. Now we need the courage to act," Richard Angell OBE writes for Attitude.
www.bloomberg.com
A ‘Miracle’ HIV Drug May Not Reach the Women Who Need It Most
Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the twice-yearly injection into doubt.
elmedicointeractivo.com
Internistas reclaman ampliar las opciones de profilaxis frente al VIH con tratamientos de larga duración - El médico interactivo
La Sociedad Española de Medicina Interna reclama ampliar las opciones de profilaxis frente al VIH con tratamientos de larga duración.
www.ahri.org
Mobile Men study: injectable PrEP beats pills for men who travel for work - Africa Health Research Institute
The first results from the Mobile Men study, presented at the 26th International Aids Conference in Brazil in July, show that long-acting injectable cabotegravir (CAB-LA) helped men who travel for wor...
www.medpagetoday.com
Cabotegravir HIV PrEP Effective Among U.S. Women Despite Treatment Interruptions
No cases of incident HIV over more than 1 year of follow-up in OPERA cohort
bhekisisa.org
#Aids2026: Three HIV announcements South Africa made in Rio - Bhekisisa
South Africa returned from the International Aids Conference in Rio with three big HIV announcements: a new dashboard tracking the roll-out of the country's six-monthly HIV prevention injection,…
bhekisisa.org
#Aids2026: Three HIV announcements South Africa made in Rio - Bhekisisa
South Africa returned from the International Aids Conference in Rio with three big HIV announcements: a new dashboard tracking the roll-out of the country's six-monthly HIV prevention injection,…
www.thewellproject.org
PrEPping for What You Don't Know
What if HIV prevention made sense to Black women?
bhekisisa.org
#Aids2026: Three HIV announcements South Africa made in Rio - Bhekisisa
South Africa returned from the International Aids Conference in Rio with three big HIV announcements: a new dashboard tracking the roll-out of the country's six-monthly HIV prevention injection,…
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.